These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 22514345)

  • 1. The ubiquitin-specific protease USP7 modulates the replication of Kaposi's sarcoma-associated herpesvirus latent episomal DNA.
    Jäger W; Santag S; Weidner-Glunde M; Gellermann E; Kati S; Pietrek M; Viejo-Borbolla A; Schulz TF
    J Virol; 2012 Jun; 86(12):6745-57. PubMed ID: 22514345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene.
    Tso FY; West JT; Wood C
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells.
    Hu J; Garber AC; Renne R
    J Virol; 2002 Nov; 76(22):11677-87. PubMed ID: 12388727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin.
    Lu J; Jha HC; Verma SC; Sun Z; Banerjee S; Dzeng R; Robertson ES
    J Virol; 2014 Apr; 88(8):4204-17. PubMed ID: 24478433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Herpesvirus 8 Interferon Regulatory Factors 1 and 3 Mediate Replication and Latency Activities via Interactions with USP7 Deubiquitinase.
    Xiang Q; Ju H; Li Q; Mei SC; Chen D; Choi YB; Nicholas J
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance.
    Skalsky RL; Hu J; Renne R
    J Virol; 2007 Sep; 81(18):9825-37. PubMed ID: 17626102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis.
    Sun Z; Jha HC; Robertson ES
    J Virol; 2015 Oct; 89(20):10206-18. PubMed ID: 26223641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KSHV LANA and EBV LMP1 induce the expression of UCH-L1 following viral transformation.
    Bentz GL; Bheda-Malge A; Wang L; Shackelford J; Damania B; Pagano JS
    Virology; 2014 Jan; 448():293-302. PubMed ID: 24314660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
    Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minichromosome Maintenance Proteins Cooperate with LANA during the G
    Dabral P; Uppal T; Rossetto CC; Verma SC
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KSHV Genome Replication and Maintenance in Latency.
    Ueda K
    Adv Exp Med Biol; 2018; 1045():299-320. PubMed ID: 29896673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
    Garber AC; Shu MA; Hu J; Renne R
    J Virol; 2001 Sep; 75(17):7882-92. PubMed ID: 11483733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection.
    Lu J; Verma SC; Cai Q; Robertson ES
    J Virol; 2011 Jul; 85(13):6148-61. PubMed ID: 21507979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1.
    Viejo-Borbolla A; Ottinger M; Brüning E; Bürger A; König R; Kati E; Sheldon JA; Schulz TF
    J Virol; 2005 Nov; 79(21):13618-29. PubMed ID: 16227282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of SSRP1 in latent replication of Kaposi's sarcoma-associated herpesvirus.
    Hu J; Liu E; Renne R
    J Virol; 2009 Nov; 83(21):11051-63. PubMed ID: 19710137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi's Sarcoma-Associated Herpesvirus LANA-Adjacent Regions with Distinct Functions in Episome Segregation or Maintenance.
    Juillard F; De León Vázquez E; Tan M; Li S; Kaye KM
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency.
    Mariggiò G; Koch S; Zhang G; Weidner-Glunde M; Rückert J; Kati S; Santag S; Schulz TF
    PLoS Pathog; 2017 Apr; 13(4):e1006335. PubMed ID: 28430817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-specific association with host and viral chromatin by Kaposi's sarcoma-associated herpesvirus LANA and its reversal during lytic reactivation.
    Mercier A; Arias C; Madrid AS; Holdorf MM; Ganem D
    J Virol; 2014 Jun; 88(12):6762-77. PubMed ID: 24696474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
    Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
    mBio; 2018 May; 9(3):. PubMed ID: 29739902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma-associated herpesvirus-encoded LANA recruits topoisomerase IIβ for latent DNA replication of the terminal repeats.
    Purushothaman P; McDowell ME; McGuinness J; Salas R; Rumjahn SM; Verma SC
    J Virol; 2012 Sep; 86(18):9983-94. PubMed ID: 22761383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.